Interaction between mitochondrial translocator protein and aging in inflammatory responses in mouse hippocampus
Kei Onn LaiiD, Nevin ThamiD, Lauren Hermes FairleyiD, Roshan Ratnakar NaikiD, Yulan WangiD, Sarah R. LangleyiD, Anna M. BarroniD
Abstract
The mitochondrial translocator protein (TSPO) is a biomarker of inflammation which is upregulated in the brain in aging and associated neurodegenerative diseases, such as Alzheimers disease (AD). Here we investigated the interaction between aging and TSPO immunomodulatory function in mouse hippocampus, a region severely affected in AD. Aging resulted in a reversal of TSPO knockout transcriptional signatures following inflammatory insult, with TSPO deletion drastically exacerbating inflammatory transcriptional responses in the aging hippocampus whilst dampening inflammation in the young hippocampus. Drugs that disrupt cell cycle and induce DNA-damage such as heat shock protein and topoisomerase inhibitors were identified to mimic the inflammatory transcriptional signature characterizing TSPO-dependent aging most closely. This TSPO-aging interaction is an important consideration in the interpretation of TSPO-targeted biomarker and therapeutic studies, as well as in vitro studies which cannot model the aging brain.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Minute- and second-scale hippocampal network dysfunctions in the 3xTgAD mouse model of Alzheimer's disease are prevented by TSPO knockout
Benjamin Vidal, Aurélien M. Badina, … Benjamin B. Tournier·Journal of Cerebral Blood Flow & MetabolismPeer-reviewed·Jun 1, 2026
- Differential mitochondrial protein interaction profile between human translocator protein and its A147T polymorphism variant
Prita Riana Asih, Anne Poljak, … Lars Matthias Ittner·PLoS ONEPeer-reviewed·May 6, 2022
- Knockout of TSPO delays and reduces amyloid, Tau, astrocytosis and behavioral dysfunctions in Alzheimer's disease.
K. Ceyzeriat, L. Meyer, … B. B. Tournier·bioRxiv·Mar 26, 2022
- A mitochondrial-immune axis drives the transcriptomic transition from brain aging to Alzheimer's disease
Amita Pal, Shehbeel Arif, … Joseph W. Guarnieri·bioRxiv·Jun 5, 2026
- Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases
Erik Nutma, Nurun Nahar Fancy, … David R. Owen·Nature CommunicationsPeer-reviewed·Aug 28, 2023
- The proneurogenic and microglial modulatory properties of botulinum toxin in the hippocampus of aging experimental mice
Jerly Helan Mary Joseph, Mercy Priyadharshini Babu Deva Irakkam, Mahesh Kandasamy·bioRxiv·Jun 14, 2024